Substance / Medication

Disopyramide

Overview

Active Ingredient
disopyramide
RxNorm CUI
3541

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years.
Massera Daniele, Sherrid Mark V, Adlestein Elizabeth et al. · J Am Heart Assoc · 2025
PMID: 39817530ObservationalFull text (PMC)
Combined effect of disopyramide and erythromycin on ventricular repolarization in dogs with complete atrioventricular block.
Watanabe Ichiro, Okumura Yasuo, Nagashima Koichi et al. · Int Heart J · 2011
PMID: 22188715Observational
In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
Schimpf Rainer, Veltmann Christian, Giustetto Carla et al. · J Cardiovasc Electrophysiol · 2007
PMID: 17711440Observational
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
Sherrid Mark V, Barac Ivan, McKenna William J et al. · J Am Coll Cardiol · 2005
PMID: 15837258Observational
Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide.
Sugao Masataka, Fujiki Akira, Nishida Kunihiro et al. · J Cardiovasc Pharmacol · 2005
PMID: 15897781Observational
Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone.
Wakaumi Michi, Tsuruoka Shuichi, Sakamoto Koichi et al. · Br J Clin Pharmacol · 2005
PMID: 15606453ObservationalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Disopyramide (substance)
SNOMED CT
372844004
UMLS CUI
C0012702
RxNorm CUI
3541

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

5
Conditions
2
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.